Summit Therapeutics has soared due to hopes around its cancer drug candidate, ivonescimab. It outperformed Keytruda in a phase 3 trial for treating advanced non-small cell lung cancer. Investors ...
Welcome back to the DLF Mailbag, the preeminent mailbag in all the dynasty fantasy football land. Much as with a wedding, this week’s NFL coaching carousel has provided us with each of the four key ...
Key equity benchmarks staged a rebound on Tuesday, snapping a two-day losing streak, after the Reserve Bank of India (RBI) announced measures to enhance liquidity in the banking system. The benchmark ...